These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 15289340)
21. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180 [TBL] [Abstract][Full Text] [Related]
22. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Zhao H; Shiina H; Greene KL; Li LC; Tanaka Y; Kishi H; Igawa M; Kane CJ; Carroll P; Dahiya R Cancer; 2005 Jul; 104(1):44-52. PubMed ID: 15895377 [TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Ueki T; Toyota M; Skinner H; Walter KM; Yeo CJ; Issa JP; Hruban RH; Goggins M Cancer Res; 2001 Dec; 61(23):8540-6. PubMed ID: 11731440 [TBL] [Abstract][Full Text] [Related]
24. VEGF masks BNIP3-mediated apoptosis of hypoxic endothelial cells. Jurasz P; Yurkova N; Kirshenbaum L; Stewart DJ Angiogenesis; 2011 May; 14(2):199-207. PubMed ID: 21318419 [TBL] [Abstract][Full Text] [Related]
25. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Cheng YY; Yu J; Wong YP; Man EP; To KF; Jin VX; Li J; Tao Q; Sung JJ; Chan FK; Leung WK Br J Cancer; 2007 Oct; 97(7):895-901. PubMed ID: 17848950 [TBL] [Abstract][Full Text] [Related]
26. Epigenetic inactivation of Betaig-h3 gene in human cancer cells. Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406 [TBL] [Abstract][Full Text] [Related]
27. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone. Manka D; Spicer Z; Millhorn DE Cancer Res; 2005 Dec; 65(24):11689-93. PubMed ID: 16357180 [TBL] [Abstract][Full Text] [Related]
28. BNIP3 induces apoptosis and protective autophagy under hypoxia in esophageal squamous cell carcinoma cell lines: BNIP3 regulates cell death. Ma Z; Chen C; Tang P; Zhang H; Yue J; Yu Z Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859361 [TBL] [Abstract][Full Text] [Related]
29. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657 [TBL] [Abstract][Full Text] [Related]
30. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Chan AS; Tsui WY; Chen X; Chu KM; Chan TL; Chan AS; Li R; So S; Yuen ST; Leung SY Oncogene; 2003 Oct; 22(44):6946-53. PubMed ID: 14534543 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895 [TBL] [Abstract][Full Text] [Related]
32. GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling. Zhang Y; Qu X; Jing W; Hu X; Yang X; Hou K; Teng Y; Zhang J; Liu Y Anticancer Drugs; 2009 Mar; 20(3):208-14. PubMed ID: 19396019 [TBL] [Abstract][Full Text] [Related]
33. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Lee SH; Kim J; Kim WH; Lee YM Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007 [TBL] [Abstract][Full Text] [Related]
34. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs. Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Chen X; Gong J; Zeng H; Chen N; Huang R; Huang Y; Nie L; Xu M; Xia J; Zhao F; Meng W; Zhou Q Cancer Res; 2010 Apr; 70(7):2728-38. PubMed ID: 20332243 [TBL] [Abstract][Full Text] [Related]
36. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849 [TBL] [Abstract][Full Text] [Related]
37. Silencing of BNIP3 results from promoter methylation by DNA methyltransferase 1 induced by the mitogen-activated protein kinase pathway. An HJ; Lee H; Paik SG Mol Cells; 2011 Jun; 31(6):579-83. PubMed ID: 21573703 [TBL] [Abstract][Full Text] [Related]
38. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
39. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312 [TBL] [Abstract][Full Text] [Related]
40. BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathway. Cosse JP; Rommelaere G; Ninane N; Arnould T; Michiels C Biochem Pharmacol; 2010 Oct; 80(8):1160-9. PubMed ID: 20637734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]